keyword
Keywords Epicardial adipose tissue and ...

Epicardial adipose tissue and obesity

https://read.qxmd.com/read/37900326/is-there-a-relationship-between-epicardial-adipose-tissue-inflammatory-markers-and-the-severity-of-covid-19-pneumonia
#21
JOURNAL ARTICLE
Aslihan Calim, Ugur Yanic, Ahmet Mesrur Halefoglu, Ayda Damar, Cigdem Ersoy, Hatice Topcu, Abdulkadir Unsal
OBJECTIVES: Epicardial adipose tissue (EAT) is a type of visceral adipose tissue with pro-inflammatory properties. We sought to examine the relationship between the EAT volume and attenuation measured on non-contrast chest computed tomography (CT), inflammation markers, and the severity of COVID-19 pneumonia. METHODS: One hundred and twenty-five patients who are over 18 years old who applied to our hospital and were found to have COVID-19 polymerase chain reaction (+) on nasopharyngeal swab sample and COVID-19 pneumonia on chest CT were included in the study...
2023: Şişli Etfal Hastanesi tıp bülteni
https://read.qxmd.com/read/37881786/epicardial-adipose-tissue-metabolic-disorders-and-cardiovascular-diseases-recent-advances-classified-by-research-methodologies
#22
REVIEW
Yujie Song, Yanzhen Tan, Meng Deng, Wenju Shan, Wenying Zheng, Bing Zhang, Jun Cui, Lele Feng, Lei Shi, Miao Zhang, Yingying Liu, Yang Sun, Wei Yi
Epicardial adipose tissue (EAT) is located between the myocardium and visceral pericardium. The unique anatomy and physiology of the EAT determines its great potential in locally influencing adjacent tissues such as the myocardium and coronary arteries. Classified by research methodologies, this study reviews the latest research progress on the role of EAT in cardiovascular diseases (CVDs), particularly in patients with metabolic disorders. Studies based on imaging techniques demonstrated that increased EAT amount in patients with metabolic disorders is associated with higher risk of CVDs and increased mortality...
December 2023: MedComm
https://read.qxmd.com/read/37848803/epicardial-adipose-tissue-a-potential-therapeutic-target-for-cardiovascular-diseases
#23
REVIEW
Wenxi Fang, Saiyang Xie, Wei Deng
With increased ageing of the population, cardiovascular disease (CVD) has become the most important factor endangering human health worldwide. Although the treatment of CVD has become increasingly advanced, there are still a considerable number of patients with conditions that have not improved. According to the latest clinical guidelines of the European Cardiovascular Association, obesity has become an independent risk factor for CVD. Adipose tissue includes visceral adipose tissue and subcutaneous adipose tissue...
October 17, 2023: Journal of Cardiovascular Translational Research
https://read.qxmd.com/read/37818284/chronic-effect-of-hotballoon-based-wide-planar-ablation-on-epicardial-adipose-tissue-in-persistent-atrial-fibrillation
#24
JOURNAL ARTICLE
Shiro Nakahara, Yuichi Hori, Reiko Fukuda, Hirotsugu Sato, Hideyuki Aoki, Tetsuya Ishikawa, Yuji Itabashi, Sayuki Kobayashi, Isao Taguchi, Yasuo Okumura
Background: Adverse atrial remodeling, including epicardial adipose tissue (EAT) deposition in the left atrium (LA), is implicated in atrial fibrillation (AF). Radiofrequency hotballoon (RHB) ablation can produce wide planar lesions because the balloon is highly compliant; however, chronic effects of RHB ablation on structural remodeling remain unknown. This clinical-experimental investigation characterized chronic effects of RHB ablation on EAT in persistent AF (PsAF). Methods and Results: The clinical study involved 91 patients (obese, n=30; non-obese, n=61) undergoing RHB ablation for PsAF...
October 10, 2023: Circulation reports
https://read.qxmd.com/read/37801237/epicardial-adipose-tissue-changes-after-bariatric-and-metabolic-surgery-a-systematic-review-and-meta-analysis
#25
REVIEW
Juan Pablo Scarano Pereira, Matteo Calafatti, Alessandro Martinino, Dharmanand Ramnarain, Christine Stier, Chetan Parmar, Sylvia Weiner, Lukas R Dekker, Till Hasenberg, Olga Wolf, Sjaak Pouwels
Epicardial adipose tissue (EAT) is a visceral fat depot located between the myocardium and visceral epicardium. Emerging evidence suggests that excessive EAT is linked to increased risk of cardiovascular conditions and other metabolic diseases. A literature search was conducted from the earliest studies to the 26th of November 2022 on PubMed, Embase, and the Cochrane. All the studies evaluating changes in EAT, pericardial adipose tissue (PAT), or total cardiac fat loss before and after BS were included. From 623 articles, 35 were eventually included in the systematic review...
October 6, 2023: Obesity Surgery
https://read.qxmd.com/read/37792133/body-fat-distribution-diabetes-mellitus-and-cardiovascular-disease-an-update
#26
REVIEW
Puneet S Kang, Ian J Neeland
PURPOSE OF REVIEW: Specific measures of body fat distribution may have particular value in the development and treatment of cardiometabolic conditions, such as cardiovascular disease (CVD) and diabetes mellitus (DM). Here, we review the pathophysiology, epidemiology, and recent advances in the identification and management of body fat distribution as it relates to DM and CVD risk. RECENT FINDINGS: Accumulation of visceral and ectopic fat is a major contributor to CVD and DM risk above and beyond the body mass index (BMI), yet implementation of fat distribution assessment into clinical practice remains a challenge...
October 4, 2023: Current Cardiology Reports
https://read.qxmd.com/read/37774476/significance-of-adipose-tissue-quantity-and-distribution-on-obesity-paradox-in-heart-failure
#27
JOURNAL ARTICLE
Saeid Mirzai, Ian Persits, Pieter Martens, Po-Hao Chen, Jerry D Estep, W H Wilson Tang
Obesity is a predictor of the development of systolic and diastolic heart failure (HF), but once established, patients with HF and obesity have better outcomes than their leaner counterparts, a phenomenon termed the "obesity paradox." We sought to investigate the impact of adipose tissue quantity and distribution, measured by way of computed tomography, on outcomes in patients with HF. Patients admitted for acute decompensated HF between January 2017 to December 2018 were retrospectively analyzed. Body composition measurements were made on computed tomography of the abdomen/pelvis...
September 27, 2023: American Journal of Cardiology
https://read.qxmd.com/read/37749614/plasma-aryl-hydrocarbon-receptor-associated-with-epicardial-adipose-tissue-in-men-a-cross-sectional-study
#28
JOURNAL ARTICLE
Yu-Cheng Cheng, Wei-Chun Ma, Yu-Hsuan Li, Junyi Wu, Kae-Woei Liang, Wen-Jane Lee, Hsiu-Chen Liu, Wayne Huey-Herng Sheu, I-Te Lee
BACKGROUND: Epicardial adipose tissue (EAT) is a type of ectopic fat with endocrine and paracrine functions. Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that responds to environmental stimuli. AhR expression is associated with obesity. In this cross-sectional study, we aimed to determine the relationship between circulating AhR concentrations and EAT. METHODS: A total of 30 men with obesity and 23 age-matched men as healthy controls were enrolled...
September 25, 2023: Diabetology & Metabolic Syndrome
https://read.qxmd.com/read/37642195/association-between-epicardial-adipose-tissue-and-cardiac-dysfunction-in-subjects-with-severe-obesity
#29
JOURNAL ARTICLE
J F Chin, Y S Aga, S Abou Kamar, D Kroon, S M Snelder, S W E van de Poll, I Kardys, J J Brugts, R A de Boer, B M van Dalen
BACKGROUND: Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. AIMS: Determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction. METHODS AND RESULTS: Subjects with BMI ≥35 kg/m2 aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled...
August 29, 2023: European Journal of Heart Failure
https://read.qxmd.com/read/37619907/amino-acids-contribute-to-adaptive-thermogenesis-new-insights-into-the-mechanisms-of-action-of-recent-drugs-for-metabolic-disorders-are-emerging
#30
REVIEW
Chiara Ruocco, Alexis Malavazos, Maurizio Ragni, Michele O Carruba, Alessandra Valerio, Gianluca Iacobellis, Enzo Nisoli
Adaptive thermogenesis is the heat production by muscle contractions (shivering thermogenesis) or brown adipose tissue (BAT) and beige fat (non-shivering thermogenesis) in response to external stimuli, including cold exposure. BAT and beige fat communicate with peripheral organs and the brain through a variegate secretory and absorption processes - controlling adipokines, microRNAs, extracellular vesicles, and metabolites - and have received much attention as potential therapeutic targets for managing obesity-related disorders...
August 22, 2023: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/37611727/exploring-the-significance-of-epicardial-adipose-tissue-in-aortic-valve-stenosis-and-left-ventricular-remodeling-unveiling-novel-therapeutic-and-prognostic-markers-of-disease
#31
REVIEW
Stefano Quarta, Giuseppe Santarpino, Maria Annunziata Carluccio, Nadia Calabriso, Michele Maffia, Luisa Siculella, Fabrizio Damiano, Rosalinda Madonna, Marika Massaro
Aortic stenosis (AS) is a dynamic degenerative process that shares many pathophysiological features with atherogenesis, from initial proinflammatory calcification and focal thickening of the valve leaflets to obstruction of left ventricular outflow due to superimposed of severe calcification and immobilization of the valve leaflets. As the prevalence increases with age, AS is expected to become one of the most common heart diseases worldwide. In both obese and nonobese patients, persistent thickening of epicardial adipose tissue (EAT) is associated with a shift in its normal metabolic functions toward a dysmetabolic and proatherogenic phenotype that may impair the physiology of adjacent coronary arteries and promote the occurrence of coronary atherosclerosis...
August 21, 2023: Vascular Pharmacology
https://read.qxmd.com/read/37572193/myocardial-tissue-remodeling-in-early-adult-obesity-and-its-association-with-regional-adipose-tissue-distribution-and-ectopic-fat-deposits-a-prospective-study
#32
JOURNAL ARTICLE
Jing Liu, Yali Qu, Jing Li, Wenzhang He, Xiaoyi Chen, Xue Li, Yinqiu Wang, Hehan Tang, Yuan Yuan, Liping Deng, Guoyong Chen, Tianying Zheng, Lisha Nie, Xiaoyue Zhou, Bin Song, Nanwei Tong, Liqing Peng
OBJECTIVES: To evaluate the left ventricular (LV) myocardial tissue characteristics in early adult obesity and its association with regional adipose tissue and ectopic fat deposition. METHODS: Forty-nine obese adults (mean body mass index: 29.9 ± 2.0 kg/m2 ) and 44 healthy controls were prospectively studied. LV native and post-contrast T1 values, extracellular volume fraction (ECV), regional adipose tissue (epicardial, visceral, and subcutaneous adipose tissue (EAT, VAT, and SAT)), and ectopic fat deposition (hepatic and pancreatic proton density fat fractions (H-PDFF and P-PDFF)) based on magnetic resonance imaging were compared...
August 12, 2023: European Radiology
https://read.qxmd.com/read/37551923/semaglutide-therapy-decreases-epicardial-fat-inflammation-and-improves-psoriasis-severity-in-patients-affected-by-abdominal-obesity-and-type-2-diabetes
#33
JOURNAL ARTICLE
Alexis Elias Malavazos, Chiara Meregalli, Fabio Sorrentino, Andrea Vignati, Carola Dubini, Valentina Scravaglieri, Sara Basilico, Federico Boniardi, Pietro Spagnolo, Piergiorgio Malagoli, Paolo Romanelli, Francesco Secchi, Gianluca Iacobellis
SUMMARY: Psoriasis is often associated with abdominal obesity and type-2 diabetes (T2D). The inflammatory process in psoriasis can target adipose tissue depots, especially those surrounding the heart and coronary arteries, exposing to an increased risk of cardiovascular diseases. A 50-year-old female patient referred to us for abdominal obesity and T2D, which were not controlled with lifestyle modifications. She had suffered from psoriasis for some years and was treated with guselkumab, without success...
August 8, 2023: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/37522825/-the-role-of-epicardial-obesity-in-the-development-of-left-ventricular-diastolic-dysfunction
#34
JOURNAL ARTICLE
O V Gritsenko, G A Chumakova, E V Trubina
AIM: To study the effect of epicardial adipose tissue on risk of left ventricular (LV) diastolic dysfunction (DD) in patients with visceral obesity. MATERIAL AND METHODS: Obesity leads to the development of LV DD and is a major cause of heart failure with preserved LV ejection fraction (HFpEF). However, the contribution of epicardial adipose tissue to DD is understudied. This study included 101 men with general obesity (body weight index, 32.9±3.6 kg /m2)...
July 28, 2023: Kardiologiia
https://read.qxmd.com/read/37468187/role-of-human-epicardial-adipose-tissue-derived-mir-92a-3p-in-myocardial%C3%A2-redox-state
#35
JOURNAL ARTICLE
Maria Cristina Carena, Ileana Badi, Murray Polkinghorne, Ioannis Akoumianakis, Costas Psarros, Elizabeth Wahome, Christos P Kotanidis, Nadia Akawi, Alexios S Antonopoulos, Jagat Chauhan, Rana Sayeed, George Krasopoulos, Vivek Srivastava, Shakil Farid, Nicholas Walcot, Gillian Douglas, Keith M Channon, Barbara Casadei, Charalambos Antoniades
BACKGROUND: Visceral obesity is directly linked to increased cardiovascular risk, including heart failure. OBJECTIVES: This study explored the ability of human epicardial adipose tissue (EAT)-derived microRNAs (miRNAs) to regulate the myocardial redox state and clinical outcomes. METHODS: This study screened for miRNAs expressed and released from human EAT and tested for correlations with the redox state in the adjacent myocardium in paired EAT/atrial biopsy specimens from patients undergoing cardiac surgery...
July 25, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37397241/epicardial-fat-in-heart-failure-with-preserved-ejection-fraction-bad-actor-or-just-lying-around
#36
REVIEW
Mary-Tiffany Oduah, Varun Sundaram, Yogesh Nv Reddy
Heart failure with preserved ejection fraction (HFpEF) is increasingly recognised to be strongly associated with obesity and abnormalities in fat distribution. Epicardial fat has been associated with abnormal haemodynamics in HFpEF, with potential for direct mechanical effects on the heart causing constriction-like physiology and local myocardial remodelling effects from secretion of inflammatory and profibrotic mediators. However, patients with epicardial fat generally have more systemic and visceral adipose tissue making determination of causality between epicardial fat and HFpEF complex...
2023: Cardiac Failure Review
https://read.qxmd.com/read/37388208/editorial-the-impact-of-adipose-tissue-dysfunction-on-cardiovascular-and-renal-disease-volume-ii
#37
EDITORIAL
Xiaodong Sun, Chengchao Ruan, Alexandre A da Silva
No abstract text is available yet for this article.
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37371748/role-of-epicardial-adipose-tissue-secretome-on-cardiovascular-diseases
#38
REVIEW
Sara Leo, Elena Tremoli, Letizia Ferroni, Barbara Zavan
Obesity and insulin resistance are associated with the inflamed and defective adipose tissue (AT) phenotype, and are established risk factors for cardiovascular diseases (CVDs). Extracellular vesicles (EVs) are a heterogeneous group of cell-derived lipid membrane vesicles involved in the onset and development of many pathologies, including insulin resistance, diabetes, and CVDs. The inflammation associated with overweight and obesity triggers the transition of the AT secretome from healthy to pathological, with a consequent increased expression of pro-inflammatory mediators...
June 7, 2023: Biomedicines
https://read.qxmd.com/read/37368514/characterizing-regional-and-global-effects-of-epicardial-adipose-tissue-on-cardiac-systolic-and-diastolic-function
#39
JOURNAL ARTICLE
Christopher M Hearon, Shiva Reddy, Katrin A Dias, Aditi Shankar, James MacNamara, Benjamin Levine, Satyam Sarma
OBJECTIVE: The aim of this retrospective study was to determine whether regional epicardial adipose tissue (EAT) exerts localized effects on adjacent myocardial left ventricular (LV) function. METHODS: Cardiac magnetic resonance imaging (MRI), echocardiography, dual-energy x-ray absorptiometry, and exercise testing were performed in 71 patients with obesity with elevated cardiac biomarkers and visceral fat. Total and regional (anterior, inferior, lateral, right ventricular) EAT was quantified by MRI...
July 2023: Obesity
https://read.qxmd.com/read/37260440/the-role-of-epicardial-adipose-tissue-dysfunction-in-cardiovascular-diseases-an-overview-of-pathophysiology-evaluation-and-management
#40
REVIEW
Cheng Li, Xinyu Liu, Binay Kumar Adhikari, Liping Chen, Wenyun Liu, Yonggang Wang, Huimao Zhang
In recent decades, the epicardial adipose tissue (EAT) has been at the forefront of scientific research because of its diverse role in the pathogenesis of cardiovascular diseases (CVDs). EAT lies between the myocardium and the visceral pericardium. The same microcirculation exists both in the epicardial fat and the myocardium. Under physiological circumstances, EAT serves as cushion and protects coronary arteries and myocardium from violent distortion and impact. In addition, EAT acts as an energy lipid source, thermoregulator, and endocrine organ...
2023: Frontiers in Endocrinology
keyword
keyword
24664
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.